Profund Advisors LLC lowered its holdings in shares of Molina Healthcare Inc (NYSE:MOH) by 26.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,690 shares of the company’s stock after selling 2,424 shares during the period. Profund Advisors LLC’s holdings in Molina Healthcare were worth $463,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Great West Life Assurance Co. Can grew its holdings in Molina Healthcare by 7.2% in the first quarter. Great West Life Assurance Co. Can now owns 25,307 shares of the company’s stock worth $1,153,000 after purchasing an additional 1,699 shares during the period. First Trust Advisors LP increased its stake in shares of Molina Healthcare by 39.5% during the first quarter. First Trust Advisors LP now owns 46,553 shares of the company’s stock valued at $2,123,000 after purchasing an additional 13,176 shares in the last quarter. Comerica Bank increased its stake in shares of Molina Healthcare by 4.5% during the first quarter. Comerica Bank now owns 32,773 shares of the company’s stock valued at $1,594,000 after purchasing an additional 1,416 shares in the last quarter. Swiss National Bank increased its stake in shares of Molina Healthcare by 1.4% during the first quarter. Swiss National Bank now owns 65,500 shares of the company’s stock valued at $2,987,000 after purchasing an additional 900 shares in the last quarter. Finally, Karp Capital Management Corp bought a new position in shares of Molina Healthcare during the first quarter valued at approximately $699,000. 96.04% of the stock is currently owned by institutional investors and hedge funds.

Molina Healthcare Inc (MOH) opened at 68.76 on Monday. Molina Healthcare Inc has a 12 month low of $42.56 and a 12 month high of $72.79. The stock’s market cap is $3.93 billion. The firm has a 50-day moving average price of $62.22 and a 200-day moving average price of $60.55.

Molina Healthcare (NYSE:MOH) last posted its earnings results on Wednesday, August 2nd. The company reported ($0.01) EPS for the quarter, missing the Zacks’ consensus estimate of $0.86 by ($0.87). The firm had revenue of $5 billion for the quarter, compared to analysts’ expectations of $4.88 billion. Molina Healthcare had a negative net margin of 1.07% and a positive return on equity of 16.10%. The company’s revenue was up 14.7% on a year-over-year basis. During the same period in the previous year, the company earned $0.67 EPS. Equities research analysts expect that Molina Healthcare Inc will post ($2.70) earnings per share for the current fiscal year.

In other news, Director John C. Molina sold 22,400 shares of the firm’s stock in a transaction on Thursday, September 28th. The stock was sold at an average price of $67.01, for a total value of $1,501,024.00. Following the completion of the sale, the director now owns 540,722 shares of the company’s stock, valued at approximately $36,233,781.22. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider William Dentino sold 66,000 shares of the firm’s stock in a transaction on Thursday, July 6th. The stock was sold at an average price of $68.68, for a total value of $4,532,880.00. The disclosure for this sale can be found here. Insiders sold 344,045 shares of company stock worth $22,316,558 over the last ninety days. Corporate insiders own 6.20% of the company’s stock.

MOH has been the topic of a number of analyst reports. Jefferies Group LLC reissued a “hold” rating and issued a $72.00 price target on shares of Molina Healthcare in a research report on Friday, July 14th. BidaskClub lowered Molina Healthcare from a “buy” rating to a “hold” rating in a research report on Friday, August 4th. Zacks Investment Research lowered Molina Healthcare from a “hold” rating to a “sell” rating in a research report on Tuesday, July 11th. Morgan Stanley began coverage on Molina Healthcare in a research note on Tuesday, June 6th. They set an “underweight” rating and a $65.00 price objective for the company. Finally, Stifel Nicolaus reiterated a “sell” rating and set a $60.00 price objective on shares of Molina Healthcare in a research note on Friday, July 14th. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and four have assigned a buy rating to the stock. Molina Healthcare presently has an average rating of “Hold” and a consensus price target of $62.90.

TRADEMARK VIOLATION NOTICE: “Profund Advisors LLC Reduces Position in Molina Healthcare Inc (MOH)” was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another website, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.watchlistnews.com/profund-advisors-llc-reduces-position-in-molina-healthcare-inc-moh/1602528.html.

Molina Healthcare Profile

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.